Am I suitable for Sculptra? Thin faces, full faces, and who is excluded

Who is suitable for Sculptra, and what the assessment looks for

Sculptra is poly-L-lactic acid, a collagen biostimulator rather than a filler. It adds almost no volume on the day; fibroblasts build collagen around the particles over the following months, and that collagen is what you eventually see. The question of suitability therefore turns on three things: whether your change is diffuse deflation, whether your skin is thick enough to hide a particle, and whether you can live with a gradual result that cannot be reversed. The Sculptra page explains the product in full; this page is about whether you qualify.

It suits the overall deflation of the midface, temples and the hollow beside the chin that comes with age or after significant weight loss, in a person whose complaint is a face that looks tired rather than lined. Dr Sin Yong examines the face at rest and in animation and separates deflation from descent and from fat. He palpates the temple and cheek for tissue thickness, because a thin covering shows every particle, and he maps earlier injectables with ultrasound before any scaffold is added, since layering a non-dissolvable product over unknown material is avoided rather than managed. Scarring history, immune status and blood-thinning medicines are taken at the same visit, and the plan is written with the option of no treatment included.

Thin faces versus full faces: which gets more from it

People assume a thin face is the obvious candidate and a full face is not. The truth is less tidy. A very lean face with little tissue above bone does have the deflation Sculptra addresses, but it also has the least cover, so the product is placed more dilute and deeper, over the bone, where the published consensus places it in thin skin. Where the tissue is so thin that a nodule would be visible, or where the hollow is a single discrete point such as one temple, Dr Sin Yong uses a reversible hyaluronic acid instead, for the reasons set out under temple filler.

A full or heavier face is examined for what the fullness is. Where the cheek is broad but the skin has thinned and lost support, a dilute scaffold in the deep subcutaneous plane can suit it well. Where the fullness is fat, or a jowl sitting on a loose jawline, adding collagen adds weight without lifting, and the plan moves to VF Lift – Vertical Facelift or to Time Freeze Laser LCLR® for a puffy face. A face already carrying earlier Sculptra, Ellansé or layered filler is scanned first, because the honest step is usually subtraction rather than more.

“Sculptra goes only where the tissue is thick enough to hide a particle and where a gradual, diffuse change is wanted. The under-eye fails both tests, so it does not go there.”

Dr Sin YongOn who is suitable for Sculptra

Is there a right age for Sculptra? Age bands, in words

There is no age at which Sculptra becomes appropriate, because it follows the tissue rather than the birthday. In a younger adult the face usually still has its fat pads and bone, and what reads as a hollow is more often a feature of their build than a loss; here a scaffold rarely earns its place, and if a single area genuinely needs support a reversible product is the sensible first step. In the years when the midface and temples first begin to deflate, and the face starts to look tired in photographs without any single line to blame, Sculptra becomes a logical option, provided the skin is still thick enough to carry it.

Later, when deflation is joined by descent and the skin itself has loosened, the picture changes again. Sculptra still addresses the deflation, but it does nothing for the jowl or the loose jawline, so the plan is usually sequenced: lifting first, then a scaffold for what remains hollow, or both planned together across visits. Where skin has become very thin with age or sun, cover becomes the limiting factor, and dilution and depth are adjusted or the product is set aside. Age, in other words, changes what else needs doing; it does not decide suitability on its own.

Who is excluded: keloid-prone skin, the under-eye and other reasons to say no

Some exclusions are firm. Sculptra is not used in anyone with a known hypersensitivity to poly-L-lactic acid or any component of the product, and not in anyone with a history of, or tendency to, keloid or hypertrophic scarring; both are contraindications in the product's US labelling, because a scaffold placed in skin that over-heals can provoke the wrong kind of tissue. The keloid and hypertrophic scar page explains what that tendency looks like. Its aesthetic indication is for people with a healthy immune system, so immune suppression is discussed carefully rather than waved through.

The under-eye is excluded by anatomy. Lid skin is the thinnest on the face and moves with every blink, so it shows every particle, and a nodule there cannot be dissolved. Dr Sin Yong does not place Sculptra in the tear trough, the lips or fine superficial lines for the same reason; where the under-eye genuinely needs volume, a soft, reversible hyaluronic acid is used, as set out under tear trough refinement, and where it needs nothing, nothing is placed.

Reasons to wait rather than to refuse

• Pregnancy and breastfeeding, where safety has not been established
• Active infection or inflammation at the sites, including an acne flare or a cold sore
• An autoimmune condition, until it has been assessed and is quiet
• Blood thinners or a bleeding tendency, reviewed because bruising is more likely
• Unmapped earlier filler or biostimulator in the planned area, scanned first

Then there are reasons of expectation. Anyone who needs a visible change before a near event, who cannot return for review, or who would be uneasy with a result that cannot be reversed is a poor candidate however suitable the anatomy. Papules and nodules were reported in a meaningful share of patients in the US pivotal trial, mostly months later and mostly resolving, and the Sculptra lumps page explains how they are assessed. That risk is part of the consent, not a footnote.

What decides the plan, if you are suitable

Fees are not advertised, and a figure before examination would describe someone else's face. What shapes the plan is the number of regions, the dilution and plane each needs, how much is placed at a first visit against how much is left for reassessment, whether a biostimulator is combined with lifting or a reversible filler, and how review is staged. Dr Sin Yong under-corrects deliberately, because the response keeps building after you leave and cannot be taken back; the how we quote page explains what the written plan contains.

If you are suitable, the product is reconstituted in advance, placed region by region with the dilution set to the tissue, and the area massaged as advised afterwards. Fullness on the day is mostly water and settles quickly; the Sculptra aftercare page covers what is normal and when to call. Any lump that is growing, painful or red is examined rather than massaged. If you are not suitable, the collagen biostimulators page sets out how Ellansé, Radiesse and Juvelook differ, and the written plan will say which, if any, fits.